Professor Tara Moore
Director of the Biomedical Sciences Research Institute
- School of Biomedical Sciences
- Research Institute
- Biomedical Sciences Research Institute
- Coleraine campus
- +44 28 7012 4577
Professor Tara Moore, PhD has a wealth of experience of working in Universities and laboratories across UK, Europe and USA focusing on novel diagnosis and treatment for blinding eye diseases.
Tara has over 120 papers published in high impact peer reviewed journals. These publications reflect internationally competitive research of high quality and is indicated by the following metrics: 1955 total citations, generating an h-index of 23 and i10-index of 38.
Tara’s research team concentrates on gene editing and gene silencing treatments for autosomal dominantly inherited eye diseases. As well as undertaking the role of Research Director for Biomedical Sciences in Ulster University Tara also concurrently holds a Research Director position with Avellino Labs USA which facilitates movement of her research findings to the clinic with rapid clinical translation. Tara holds a number of patents and her research at Ulster has secured a number of licensing agreements with local, national and international companies including Sisaf, Almac and Avellino Labs USA.
Tara is a mentor for the New York Academy of Science 1000Girls, 1000Futures initiative from the Global Stem Alliance. Tara’s research activities are disseminated worldwide through her contribution to guest lectures and workshops spanning UK, Europe, USA and Middle East.
The culmination of Professor Moore’s contribution to health, well-being and safety and improving people’s lives whilst inspiring others to see the opportunities to make a difference through science was recognised with the prestigious WISE award presented by HRH Princess Anne and most recently a prestigious Winston Churchill Fellowship.
Showing 1 to 10 of 138 publications
To view all publications please visit Ulster University Institutional Repository (UIR)
- Comparison of the quality of vision and visual performance between two refractive rotationally asymmetric multifocal intraocular lensesJournal of Cataract and Refactive SurgeryDate: (2017)
- TGFBI Gene Mutation Analysis of Clinically Diagnosed Granular Corneal Dystrophy Patients Prior to PTK: A Pilot Study from Eastern ChinaScientific ReportsDate: (2017)
- Rotationally asymmetric multifocal Intraocular Lenses: Preoperative considerations and Postoperative outcomesCurrent Opinion in OphthalmologyDate: (2016)
- Comparison of the visual performance and quality of vision produced by combined symmetrical inferonasal near addition versus inferonasal / superotemporal placement of rotationally asymmetric refractive multifocal intraocular lensesJournal of Cataract & Refractive SurgeryDate: (2016)
- Potential Effects of Corneal Cross-Linking upon the LimbusBioMed Research InternationalDate: (2016)
- Threshold limit of postoperative astigmatism for patient satisfaction after refractive lens exchange and multifocal intraocular lens implantationJournal of Cataract and Refractive SurgeryDate: (2016)
- Optimised Visual Outcome After Asymmetrical Multifocal IOL RotationJournal of Refractive SurgeryDate: (2016)
- Introduction of a Toric Intraocular Lens to a Non-Refractive Cataract Practice: Challenges and OutcomesInternational Journal of Ophthalmology and Clinical ResearchDate: (2016)
- Long-term Visual and Refractive Outcomes After LASIK for High Myopia and Astigmatism From −8.00 to −14.25 DJournal of Refractive SurgeryDate: (2016)
- Keratin 12 missense mutation induces the unfolded protein response and apoptosis in Meesmann epithelial corneal dystrophy.Human Molecular GeneticsDate: (2016)